Ayda Saldivar
Abbott Fund(US)
Publications by Year
Research Areas
HIV/AIDS drug development and treatment, HIV Research and Treatment, Click Chemistry and Applications, Pneumocystis jirovecii pneumonia detection and treatment, Biochemical and Molecular Research
Most-Cited Works
- → ABT-378, a Highly Potent Inhibitor of the Human Immunodeficiency Virus Protease(1998)468 cited
- → Discovery of Ritonavir, a Potent Inhibitor of HIV Protease with High Oral Bioavailability and Clinical Efficacy(1998)204 cited
- → Symmetry-based inhibitors of HIV protease. Structure-activity studies of acylated 2,4-diamino-1,5-diphenyl-3-hydroxypentane and 2,5-diamino-1,6-diphenylhexane-3,4-diol(1993)130 cited
- → Influenza Neuraminidase Inhibitors: Structure-Based Design of a Novel Inhibitor Series(2003)128 cited
- → Induction of calf thymus topoisomerase II-mediated DNA breakage by the antibacterial isothiazoloquinolones A-65281 and A-65282(1992)63 cited
- → A Novel, Picomolar Inhibitor of Human Immunodeficiency Virus Type 1 Protease(1996)62 cited
- → Design of orally bioavailable, symmetry-based inhibitors of HIV protease(1994)56 cited
- → Novel lopinavir analogues incorporating non-Aromatic P-1 side chains—Synthesis and structure–Activity relationships(2002)52 cited
- → Synthesis and activity of N-acyl azacyclic urea HIV-1 protease inhibitors with high potency against multiple drug resistant viral strains(2005)24 cited
- → Synthesis and structure–activity relationships of a novel series of HIV-1 protease inhibitors encompassing ABT-378 (Lopinavir)(2002)23 cited